112 related articles for article (PubMed ID: 17217397)
1. P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model.
Schrickx J; Fink-Gremmels J
J Vet Pharmacol Ther; 2007 Feb; 30(1):25-31. PubMed ID: 17217397
[TBL] [Abstract][Full Text] [Related]
2. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
Arima H; Yunomae K; Hirayama F; Uekama K
J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
[TBL] [Abstract][Full Text] [Related]
3. Transport of dietary phenethyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein.
Ji Y; Morris ME
Biochem Pharmacol; 2005 Aug; 70(4):640-7. PubMed ID: 16002050
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective and multiple carrier-mediated transport of cetirizine across Caco-2 cell monolayers with potential drug interaction.
He Y; Liu Y; Zeng S
Chirality; 2010 Jul; 22(7):684-92. PubMed ID: 20014242
[TBL] [Abstract][Full Text] [Related]
5. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.
Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J
Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072
[TBL] [Abstract][Full Text] [Related]
6. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein.
Griffin J; Fletcher N; Clemence R; Blanchflower S; Brayden DJ
J Vet Pharmacol Ther; 2005 Jun; 28(3):257-65. PubMed ID: 15953199
[TBL] [Abstract][Full Text] [Related]
7. Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug.
Jin HE; Song B; Kim SB; Shim WS; Kim DD; Chong S; Chung SJ; Shim CK
Xenobiotica; 2013 Apr; 43(4):355-67. PubMed ID: 23020787
[TBL] [Abstract][Full Text] [Related]
8. Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers.
He Y; Zeng S
J Pharm Pharmacol; 2005 Oct; 57(10):1297-303. PubMed ID: 16259758
[TBL] [Abstract][Full Text] [Related]
9. Methadone inhibits rhodamine123 transport in Caco-2 cells.
Störmer E; Perloff MD; von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2001 Jul; 29(7):954-6. PubMed ID: 11408360
[TBL] [Abstract][Full Text] [Related]
10. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
11. Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer.
Sugihara N; Toyama K; Michihara A; Akasaki K; Tsuji H; Furuno K
Toxicology; 2006 Jun; 223(1-2):156-65. PubMed ID: 16647797
[TBL] [Abstract][Full Text] [Related]
12. Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery.
Balimane PV; Patel K; Marino A; Chong S
Eur J Pharm Biopharm; 2004 Jul; 58(1):99-105. PubMed ID: 15207543
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of fruit extracts on P-glycoprotein-related efflux carriers: an in-vitro screening.
Deferme S; Van Gelder J; Augustijns P
J Pharm Pharmacol; 2002 Sep; 54(9):1213-9. PubMed ID: 12356275
[TBL] [Abstract][Full Text] [Related]
14. Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells.
Hansen TS; Nilsen OG
Phytother Res; 2009 Jan; 23(1):86-91. PubMed ID: 18688789
[TBL] [Abstract][Full Text] [Related]
15. Muscle tissue kinetics of oxytetracycline following intramuscular and oral administration at two dosages to giant freshwater shrimp (Macrobrachium rosenbergii).
Poapolathep A; Poapolathep S; Jermnak U; Imsilp K; Wannapat N; Sugita-Konishi Y; Kumagai S
J Vet Pharmacol Ther; 2008 Dec; 31(6):517-22. PubMed ID: 19000273
[TBL] [Abstract][Full Text] [Related]
16. In-vitro respiratory drug absorption models possess nominal functional P-glycoprotein activity.
Madlova M; Bosquillon C; Asker D; Dolezal P; Forbes B
J Pharm Pharmacol; 2009 Mar; 61(3):293-301. PubMed ID: 19222901
[TBL] [Abstract][Full Text] [Related]
17. Development of an in silico model for predicting efflux substrates in Caco-2 cells.
Zhang L; Balimane PV; Johnson SR; Chong S
Int J Pharm; 2007 Oct; 343(1-2):98-105. PubMed ID: 17583455
[TBL] [Abstract][Full Text] [Related]
18. Modulation of paclitaxel transport by flavonoid derivatives in human breast cancer cells. Is there a correlation between binding affinity to NBD of P-gp and modulation of transport?
Václavíková R; Boumendjel A; Ehrlichová M; Kovár J; Gut I
Bioorg Med Chem; 2006 Jul; 14(13):4519-25. PubMed ID: 16516478
[TBL] [Abstract][Full Text] [Related]
19. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.
Li M; Yuan H; Li N; Song G; Zheng Y; Baratta M; Hua F; Thurston A; Wang J; Lai Y
Eur J Pharm Sci; 2008 Sep; 35(1-2):114-26. PubMed ID: 18639632
[TBL] [Abstract][Full Text] [Related]
20. Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells.
Acharya P; O'Connor MP; Polli JW; Ayrton A; Ellens H; Bentz J
Drug Metab Dispos; 2008 Feb; 36(2):452-60. PubMed ID: 17967933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
